TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
Tóm tắt
Liver fibrosis is an advanced liver disease condition, which could progress to cirrhosis and hepatocellular carcinoma. To date, there is no direct approved antifibrotic therapy, and current treatment is mainly the removal of the causative factor. Transforming growth factor (TGF)-β is a master profibrogenic cytokine and a promising target to treat fibrosis. However, TGF-β has broad biological functions and its inhibition induces non-desirable side effects, which override therapeutic benefits. Therefore, understanding the pleiotropic effects of TGF-β and its upstream and downstream regulatory mechanisms will help to design better TGF-β based therapeutics. Here, we summarize recent discoveries and milestones on the TGF-β signaling pathway related to liver fibrosis and hepatic stellate cell (HSC) activation, emphasizing research of the last five years. This comprises impact of TGF-β on liver fibrogenesis related biological processes, such as senescence, metabolism, reactive oxygen species generation, epigenetics, circadian rhythm, epithelial mesenchymal transition, and endothelial-mesenchymal transition. We also describe the influence of the microenvironment on the response of HSC to TGF-β. Finally, we discuss new approaches to target the TGF-β pathway, name current clinical trials, and explain promises and drawbacks that deserve to be adequately addressed.
Từ khóa
Tài liệu tham khảo
Willis, M.S., Yates, C.C., and Schisler, J.C. (2019). Liver Fibrosis: Current Approaches and Future Directions for Diagnosis and Treatment. Fibrosis in Disease: An Organ-Based Guide to Disease Pathophysiology and Therapeutic Considerations, Springer.
Friedman, 2011, Pathogenesis of liver fibrosis, Annu. Rev. Pathol., 6, 425, 10.1146/annurev-pathol-011110-130246
Ni, 2017, Pathological process of liver sinusoidal endothelial cells in liver diseases, World J. Gastroenterol., 23, 7666, 10.3748/wjg.v23.i43.7666
Elpek, 2014, Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update, World J. Gastroenterol., 20, 7260, 10.3748/wjg.v20.i23.7260
Seki, 2015, Recent advancement of molecular mechanisms of liver fibrosis, J. Hepato-Biliary-Pancreat. Sci., 22, 512, 10.1002/jhbp.245
Pellicoro, 2014, Liver fibrosis and repair: Immune regulation of wound healing in a solid organ, Nat. Rev. Immunol., 14, 181, 10.1038/nri3623
Zhao, 2016, Epithelial-mesenchymal transition in liver fibrosis, Biomed. Rep., 4, 269, 10.3892/br.2016.578
Fabregat, 2018, Transforming growth factor-β-induced cell plasticity in liver fibrosis and hepatocarcinogenesis, Front. Oncol., 8, 357, 10.3389/fonc.2018.00357
Tsuchida, 2017, Mechanisms of hepatic stellate cell activation, Nat. Rev. Gastroenterol. Hepatol., 14, 397, 10.1038/nrgastro.2017.38
Dewidar, 2015, TGF-β in hepatic stellate cell activation and liver fibrogenesis: Updated, Curr. Pathobiol. Rep., 3, 291, 10.1007/s40139-015-0089-8
Schon, 2014, Immunomodulatory effects of transforming growth factor-β in the liver, Hepatobiliary Surg. Nutr., 3, 386
Ghafoory, 2018, Platelet TGF-β1 deficiency decreases liver fibrosis in a mouse model of liver injury, Blood Adv., 2, 470, 10.1182/bloodadvances.2017010868
Derynck, 2019, Specificity, versatility, and control of TGF-β family signaling, Sci. Signal., 12, eaav5183, 10.1126/scisignal.aav5183
Dickson, 1995, Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice, Development, 121, 1845, 10.1242/dev.121.6.1845
Kaartinen, 1995, Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction, Nat. Genet., 11, 415, 10.1038/ng1295-415
Sanford, 1997, TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes, Development, 124, 2659, 10.1242/dev.124.13.2659
Fabregat, 2016, IT-LIVER Consortium TGF-β signalling and liver disease, FEBS J., 283, 2219, 10.1111/febs.13665
Dropmann, 2016, TGF-β1 and TGF-β2 abundance in liver diseases of mice and men, Oncotarget, 7, 19499, 10.18632/oncotarget.6967
Dawood, 2018, Extrahepatic upregulation of transforming growth factor beta 2 in HCV genotype 4-induced liver fibrosis, J. Int. Soc. Interferon Cytokine Res., 38, 341, 10.1089/jir.2018.0045
Chida, 2017, Critical role of CREBH-mediated induction of transforming growth factor β2 by hepatitis C virus infection in fibrogenic responses in hepatic stellate cells, Hepatology., 66, 1430, 10.1002/hep.29319
Robertson, 2016, Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins, Cold Spring Harb. Perspect. Biol., 8, a021907, 10.1101/cshperspect.a021907
Khan, 2016, The role of integrins in TGFβ activation in the tumour stroma, Cell Tissue Res., 365, 657, 10.1007/s00441-016-2474-y
Nishimura, 2009, Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders, Am. J. Pathol., 175, 1362, 10.2353/ajpath.2009.090393
Fan, 2019, ECM1 Prevents activation of transforming growth factor beta, hepatic stellate cells, and fibrogenesis in mice, Gastroenterology, 157, 1352, 10.1053/j.gastro.2019.07.036
Carthy, 2018, TGFβ signaling and the control of myofibroblast differentiation: Implications for chronic inflammatory disorders, J. Cell. Physiol., 233, 98, 10.1002/jcp.25879
Moustakas, A., and Miyazawa, K. (2013). Transforming Growth Factor-β Signaling. TGF-β in Human Disease, Springer.
Levy, 2005, Smad4 dependency defines two classes of transforming growth factor β (TGF-β) target genes and distinguishes TGF-β-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses, Mol. Cell. Biol., 25, 8108, 10.1128/MCB.25.18.8108-8125.2005
Zhang, 2017, Non-Smad Signaling Pathways of the TGF-β Family, Cold Spring Harb. Perspect. Biol., 9, a022129, 10.1101/cshperspect.a022129
Lee, 2004, Smad2 mediates Erk1/2 activation by TGF-beta1 in suspended, but not in adherent, gastric carcinoma cells, Int. J. Oncol., 24, 1229
Zhang, 2004, A transforming growth factor beta-induced Smad3/Smad4 complex directly activates protein kinase A, Mol. Cell. Biol., 24, 2169, 10.1128/MCB.24.5.2169-2180.2004
Perlman, 2001, TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation, Nat. Cell Biol., 3, 708, 10.1038/35087019
Kretzschmar, 1997, Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1, Nature, 389, 618, 10.1038/39348
Yang, 2008, Transforming growth factor β: Tumor suppressor or promoter? Are host immune cells the answer?, Cancer Res., 68, 9107, 10.1158/0008-5472.CAN-08-2556
Yoshida, K., Matsuzaki, K., Murata, M., Yamaguchi, T., Suwa, K., and Okazaki, K. (2018). Clinico-Pathological importance of TGF-β/phospho-smad signaling during human hepatic fibrocarcinogenesis. Cancers, 10.
Simeone, 2001, Smad4 mediates activation of mitogen-activated protein kinases by TGF-beta in pancreatic acinar cells, Am. J. Physiol. Cell Physiol., 281, C311, 10.1152/ajpcell.2001.281.1.C311
Olsson, 2001, Transforming growth factor-beta-mediated mast cell migration depends on mitogen-activated protein kinase activity, Cell. Signal., 13, 483, 10.1016/S0898-6568(01)00176-0
Lee, 2007, TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA, Embo J., 26, 3957, 10.1038/sj.emboj.7601818
Xu, 2016, TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis, J. Histochem. Cytochem., 64, 157, 10.1369/0022155415627681
Xu, 2016, Smad2 increases the apoptosis of activated human hepatic stellate cells induced by TRAIL, Int. Immunopharmacol., 32, 76, 10.1016/j.intimp.2016.01.013
Khalil, 2017, Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis, J. Clin. Investig., 127, 3770, 10.1172/JCI94753
Carthy, 2015, Tamoxifen inhibits TGF-β-mediated activation of myofibroblasts by blocking non-smad signaling through ERK1/2, J. Cell. Physiol., 230, 3084, 10.1002/jcp.25049
Ard, 2019, Sustained smad2 phosphorylation is required for myofibroblast transformation in response to TGF-β, Am. J. Respir. Cell Mol. Biol., 60, 367, 10.1165/rcmb.2018-0252LE
Park, 2005, Fine tuning and cross-talking of TGF-beta signal by inhibitory Smads, J. Biochem. Mol. Biol., 38, 9
Goto, 2007, Selective inhibitory effects of Smad6 on bone morphogenetic protein type I receptors, J. Biol. Chem., 282, 20603, 10.1074/jbc.M702100200
Shi, 2004, GADD34–PP1c recruited by Smad7 dephosphorylates TGFβ type I receptor, J. Cell Biol., 164, 291, 10.1083/jcb.200307151
Kavsak, 2000, Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation, Mol. Cell, 6, 1365, 10.1016/S1097-2765(00)00134-9
Malonis, 2017, RNF11 sequestration of the E3 ligase SMURF2 on membranes antagonizes SMAD7 down-regulation of transforming growth factor β signaling, J. Biol. Chem., 292, 7435, 10.1074/jbc.M117.783662
Zhang, 2017, Breast cancer metastasis suppressor OTUD1 deubiquitinates SMAD7, Nat. Commun., 8, 2116, 10.1038/s41467-017-02029-7
Chandhoke, 2016, The ubiquitin ligase Smurf2 suppresses TGFβ-induced epithelial–mesenchymal transition in a sumoylation-regulated manner, Cell Death Differ., 23, 876, 10.1038/cdd.2015.152
Shihata, 2017, Is there a potential therapeutic role for caveolin-1 in fibrosis?, Front. Pharm., 8, 567, 10.3389/fphar.2017.00567
Wrana, 2005, Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling, Nat. Rev. Mol. Cell Biol., 6, 112, 10.1038/nrm1571
Meyer, 2011, Distinct role of endocytosis for Smad and non-Smad TGF-β signaling regulation in hepatocytes, J. Hepatol., 55, 369, 10.1016/j.jhep.2010.11.027
Ji, 2018, Cav-1 deficiency promotes liver fibrosis in carbon tetrachloride (CCl4)-induced mice by regulation of oxidative stress and inflammation responses, Biomed. Pharm. Biomed. Pharm., 102, 26, 10.1016/j.biopha.2018.03.016
Lu, J., Zhang, J., Wang, Y., and Sun, Q. (2018). Caveolin-1 scaffolding domain peptides alleviate liver fibrosis by inhibiting tgf-β1/smad signaling in mice. Int. J. Mol. Sci., 19.
Meyer, 2013, Caveolin-1 abrogates TGF-β mediated hepatocyte apoptosis, Cell Death Dis., 4, e466, 10.1038/cddis.2012.204
Meyer, 2013, Distinct dedifferentiation processes affect caveolin-1 expression in hepatocytes, Cell Commun. Signal., 11, 6, 10.1186/1478-811X-11-6
Li, M., Chen, D., Huang, H., Wang, J., Wan, X., Xu, C., Li, C., Ma, H., Yu, C., and Li, Y. (2017). Caveolin1 protects against diet induced hepatic lipid accumulation in mice. PLoS ONE, 12.
Yang, 2019, Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis, Sci. Transl. Med., 11, eaat9284, 10.1126/scitranslmed.aat9284
Zhang, 2012, HAb18G/CD147 promotes activation of hepatic stellate cells and is a target for antibody therapy of liver fibrosis, J. Hepatol., 57, 1283, 10.1016/j.jhep.2012.07.042
Li, 2015, Activation of TGF-β1-CD147 positive feedback loop in hepatic stellate cells promotes liver fibrosis, Sci. Rep., 5, 16552, 10.1038/srep16552
Shibanuma, 1994, Characterization of the TGF beta 1-inducible hic-5 gene that encodes a putative novel zinc finger protein and its possible involvement in cellular senescence, J. Biol. Chem., 269, 26767, 10.1016/S0021-9258(18)47085-8
Varney, 2016, Hic-5 is required for myofibroblast differentiation by regulating mechanically dependent MRTF-A nuclear accumulation, J. Cell Sci., 129, 774
Lei, 2016, Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice, J. Hepatol., 64, 110, 10.1016/j.jhep.2015.08.026
Kladney, 2002, Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease, Hepatology, 35, 1431, 10.1053/jhep.2002.32525
Yang, 2019, GP73, a novel TGF-β target gene, provides selective regulation on Smad and non-Smad signaling pathways, Biochim. Biophys. Acta Mol. Cell Res., 1866, 588, 10.1016/j.bbamcr.2019.01.001
Earl, 2011, Galectin multimerization and lattice formation are regulated by linker region structure, Glycobiology, 21, 6, 10.1093/glycob/cwq144
Wu, 2011, Targeting galectin-1 in carcinoma-associated fibroblasts inhibits oral squamous cell carcinoma metastasis by downregulating MCP-1/CCL2 expression, Clin. Cancer Res., 17, 1306, 10.1158/1078-0432.CCR-10-1824
Tsutsumi, 2003, Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice, Hepatology, 38, 820, 10.1002/hep.1840380408
Wu, 2017, Glycosylation-dependent galectin-1/neuropilin-1 interactions promote liver fibrosis through activation of TGF-β- and PDGF-like signals in hepatic stellate cells, Sci. Rep., 7, 11006, 10.1038/s41598-017-11212-1
Chen, 2015, Lipin family proteins—Key regulators in lipid metabolism, Ann. Nutr. Metab., 66, 10, 10.1159/000368661
Finck, 2006, Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway, Cell Metab., 4, 199, 10.1016/j.cmet.2006.08.005
Jang, 2016, The Role of Lipin-1 in the Regulation of Fibrogenesis and TGF-β Signaling in Hepatic Stellate Cells, Toxicol. Sci., 153, 28, 10.1093/toxsci/kfw109
Wang, 2017, Notch signaling mediated by TGF-β/Smad pathway in concanavalin A-induced liver fibrosis in rats, World J. Gastroenterol., 23, 2330, 10.3748/wjg.v23.i13.2330
Shen, 2016, Delta-like ligand 4 modulates liver damage by down-regulating chemokine expression, Am. J. Pathol., 186, 1874, 10.1016/j.ajpath.2016.03.010
Xiong, 2017, Positive feedback loop of YB-1 interacting with Smad2 promotes liver fibrosis, Biochem. Biophys. Res. Commun., 484, 753, 10.1016/j.bbrc.2017.01.148
Kolliopoulos, 2019, Transforming growth factor β (TGFβ) induces NUAK kinase expression to fine-tune its signaling output, J. Biol. Chem., 294, 4119, 10.1074/jbc.RA118.004984
Liu, 2013, Transforming growth factor-β (TGF-β)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation, J. Biol. Chem., 288, 30708, 10.1074/jbc.M113.478685
Tang, 2017, Transforming growth factor-β (TGF-β) Directly activates the JAK1-STAT3 axis to induce hepatic fibrosis in coordination with the SMAD pathway, J. Biol. Chem., 292, 4302, 10.1074/jbc.M116.773085
Wang, 2016, STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling, Oncogene, 35, 4388, 10.1038/onc.2015.446
Yoon, 2015, Phosphorylation status determines the opposing functions of Smad2/Smad3 as STAT3 cofactors in TH17 differentiation, Nat. Commun., 6, 7600, 10.1038/ncomms8600
Kim, 2019, TTC3 contributes to TGF-β1-induced epithelial-mesenchymal transition and myofibroblast differentiation, potentially through SMURF2 ubiquitylation and degradation, Cell Death Dis., 10, 92, 10.1038/s41419-019-1308-8
Iwaisako, 2014, Origin of myofibroblasts in the fibrotic liver in mice, Proc. Natl. Acad. Sci. USA, 111, E3297, 10.1073/pnas.1400062111
Pastan, 2014, Discovery of mesothelin and exploiting it as a target for immunotherapy, Cancer Res., 74, 2907, 10.1158/0008-5472.CAN-14-0337
Koyama, 2017, Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis, J. Clin. Investig., 127, 1254, 10.1172/JCI88845
Herrera, B., Addante, A., and Sánchez, A. (2017). BMP Signalling at the crossroad of liver fibrosis and regeneration. Int. J. Mol. Sci., 19.
Meyer, 2017, BMP-9 interferes with liver regeneration and promotes liver fibrosis, Gut, 66, 939, 10.1136/gutjnl-2016-313314
Chung, 2018, BMP-2 restoration aids in recovery from liver fibrosis by attenuating TGF-β1 signaling, Lab. Investig. J. Tech. Methods Pathol., 98, 999, 10.1038/s41374-018-0069-9
Zhang, 2017, Gremlin1 Accelerates Hepatic Stellate Cell Activation Through Upregulation of TGF-Beta Expression, DNA Cell Biol., 36, 603, 10.1089/dna.2017.3707
Iraburu, 2019, Role of AGAP2 in the profibrogenic effects induced by TGFβ in LX-2 hepatic stellate cells, Biochim. Biophys. Acta Mol. Cell Res., 1866, 673, 10.1016/j.bbamcr.2019.01.008
2002, Factor VII activating protease (FSAP): A novel protease in hemostasis, Biol. Chem., 383, 1119
Leiting, 2016, Transforming growth factor-β (TGF-β) inhibits the expression of factor vii-activating protease (FSAP) in hepatocytes, J. Biol. Chem., 291, 21020, 10.1074/jbc.M116.744631
Zimmermann, 2013, Factor VII activating protease (FSAP) exerts anti-inflammatory and anti-fibrotic effects in liver fibrosis in mice and men, J. Hepatol., 58, 104, 10.1016/j.jhep.2012.09.007
Wasmuth, 2009, The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BB, Hepatology, 49, 775, 10.1002/hep.22707
Spanjer, 2016, TGF-β-induced profibrotic signaling is regulated in part by the WNT receptor Frizzled-8, FASEB J., 30, 1823, 10.1096/fj.201500129
Beljaars, 2017, WNT-5A regulates TGF-β-related activities in liver fibrosis, Am. J. Physiol. Gastrointest. Liver Physiol., 312, G219, 10.1152/ajpgi.00160.2016
Augustin, 2017, Organotypic vasculature: From descriptive heterogeneity to functional pathophysiology, Science, 357, eaal2379, 10.1126/science.aal2379
Karin, 2016, The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis, Differ. Res. Biol. Divers., 92, 84
Sun, 2015, Reversibility of liver fibrosis, Clin. Res. Hepatol. Gastroenterol., 39, S60, 10.1016/j.clinre.2015.06.015
Puche, 2013, Hepatic stellate cells and liver fibrosis, Compr. Physiol., 3, 1473, 10.1002/cphy.c120035
Heymann, 2009, Monocytes and macrophages as cellular targets in liver fibrosis, Inflamm. Allergy Drug Targets, 8, 307, 10.2174/187152809789352230
Krenkel, 2017, Liver macrophages in tissue homeostasis and disease, Nat. Rev. Immunol., 17, 306, 10.1038/nri.2017.11
Schuppan, 2001, Matrix as a modulator of hepatic fibrogenesis, Semin. Liver Dis., 21, 351, 10.1055/s-2001-17556
Henderson, 2013, Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs, Nat. Med., 19, 1617, 10.1038/nm.3282
Olaso, 2001, DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells, J. Clin. Investig., 108, 1369, 10.1172/JCI200112373
Bansal, 2017, Integrin alpha 11 in the regulation of the myofibroblast phenotype: Implications for fibrotic diseases, Exp. Mol. Med., 49, e396, 10.1038/emm.2017.213
Greenhalgh, 2019, Loss of integrin αvβ8 in murine hepatocytes accelerates liver regeneration, Am. J. Pathol., 189, 258, 10.1016/j.ajpath.2018.10.007
Rognoni, 2016, The kindlin family: Functions, signaling properties and implications for human disease, J. Cell Sci., 129, 17, 10.1242/jcs.161190
Yu, 2018, Kindlin-2 regulates hepatic stellate cells activation and liver fibrogenesis, Cell Death Discov., 4, 34, 10.1038/s41420-018-0095-9
Zollinger, 2017, Fibronectin, the extracellular glue, Matrix Biol. J. Int. Soc. Matrix Biol., 60–61, 27, 10.1016/j.matbio.2016.07.011
Klingberg, 2018, The fibronectin ED-A domain enhances recruitment of latent TGF-β-binding protein-1 to the fibroblast matrix, J. Cell Sci., 131, jcs201293, 10.1242/jcs.201293
Peters, 1996, Fibronectin isoform distribution in the mouse. I. The alternatively spliced EIIIB, EIIIA, and V segments show widespread codistribution in the developing mouse embryo, Cell Adhes. Commun., 4, 103, 10.3109/15419069609010766
Zent, 2018, Signaling Mechanisms of Myofibroblastic Activation: Outside-in and Inside-Out, Cell. Physiol. Biochem., 49, 848, 10.1159/000493217
Muro, 2008, An essential role for fibronectin extra type III domain A in pulmonary fibrosis, Am. J. Respir. Crit. Care Med., 177, 638, 10.1164/rccm.200708-1291OC
Kawelke, N., Vasel, M., Sens, C., von Au, A., Dooley, S., and Nakchbandi, I.A. (2011). Fibronectin protects from excessive liver fibrosis by modulating the availability of and responsiveness of stellate cells to active TGF-β. PLoS ONE, 6.
Altrock, 2015, Inhibition of fibronectin deposition improves experimental liver fibrosis, J. Hepatol., 62, 625, 10.1016/j.jhep.2014.06.010
Phanish, 2015, The regulation of TGFβ1 Induced fibronectin eda exon alternative splicing in human renal proximal tubule epithelial cells, J. Cell. Physiol., 230, 286, 10.1002/jcp.24703
Li, 2019, Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-β signaling, EBioMedicine, 40, 43, 10.1016/j.ebiom.2019.01.009
Santos, 2018, Matrix stiffness: The conductor of organ fibrosis, Curr. Rheumatol. Rep., 20, 2, 10.1007/s11926-018-0710-z
Lampi, 2018, Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials, Sci. Transl. Med., 10, eaao0475, 10.1126/scitranslmed.aao0475
Caliari, 2016, Gradually softening hydrogels for modeling hepatic stellate cell behavior during fibrosis regression, Integr. Biol. Quant. Biosci. Nano Macro, 8, 720
Kanta, 2016, The role of cytokines TGF-beta1 and FGF-1 in the expression of characteristic markers of rat liver myofibroblasts cultured in three-dimensional collagen gel, Physiol. Res., 65, 661
Siegel, 1970, Cross-linking of collagen and elastin. Properties of lysyl oxidase, Biochemistry, 9, 4486, 10.1021/bi00825a004
Liu, 2016, Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice, FASEB J., 30, 1599, 10.1096/fj.14-268425
Ma, 2018, Knockdown of LOXL1 inhibits TGF-β1-induced proliferation and fibrogenesis of hepatic stellate cells by inhibition of Smad2/3 phosphorylation, Biomed. Pharm. Biomed. Pharm., 107, 1728, 10.1016/j.biopha.2018.08.156
Mesarwi, 2015, Lysyl Oxidase as a serum biomarker of liver fibrosis in patients with severe obesity and obstructive sleep apnea, Sleep, 38, 1583, 10.5665/sleep.5052
Wang, 2017, The functional relationship between transglutaminase 2 and transforming growth factor β1 in the regulation of angiogenesis and endothelial-mesenchymal transition, Cell Death Dis., 8, e3032, 10.1038/cddis.2017.399
Verderio, 1999, Regulation of cell surface tissue transglutaminase: Effects on matrix storage of latent transforming growth factor-beta binding protein-1, J. Histochem. Cytochem., 47, 1417, 10.1177/002215549904701108
Weiskirchen, 2016, Liver fibrosis: From pathogenesis to novel therapies, Dig. Dis., 34, 410, 10.1159/000444556
Lodyga, 2019, Cadherin-11-mediated adhesion of macrophages to myofibroblasts establishes a profibrotic niche of active TGF-β, Sci. Signal., 12, e3469, 10.1126/scisignal.aao3469
Cai, 2018, CXCL6-EGFR-induced Kupffer cells secrete TGF-β1 promoting hepatic stellate cell activation via the SMAD2/BRD4/C-MYC/EZH2 pathway in liver fibrosis, J. Cell. Mol. Med., 22, 5050, 10.1111/jcmm.13787
Fabre, 2018, Type 3 cytokines IL-17A and IL-22 drive TGF-β-dependent liver fibrosis, Sci. Immunol., 3, e7754, 10.1126/sciimmunol.aar7754
Shi, 2017, Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-β-dependent emperipolesis in HBV cirrhotic patients, Sci. Rep., 7, 44544, 10.1038/srep44544
Ng, 2005, Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro, J. Cell Sci., 118, 4731, 10.1242/jcs.02605
Nithiananthan, 2017, Physiological fluid flow moderates fibroblast responses to TGF-β1, J. Cell. Biochem., 118, 878, 10.1002/jcb.25767
Ansorge, 2017, Mimicking paracrine TGFβ1 Signals during myofibroblast differentiation in 3D Collagen networks, Sci. Rep., 7, 5664, 10.1038/s41598-017-05912-x
Zi, 2011, Quantitative analysis of transient and sustained transforming growth factor-β signaling dynamics, Mol. Syst. Biol., 7, 492, 10.1038/msb.2011.22
Feng, 2016, Measuring TGF-β ligand dynamics in culture medium, Methods Mol. Biol., 1344, 379, 10.1007/978-1-4939-2966-5_25
Hara, 2014, LAP degradation product reflects plasma kallikrein-dependent TGF-β activation in patients with hepatic fibrosis, SpringerPlus, 3, 221, 10.1186/2193-1801-3-221
Hara, 2015, L59 TGF-β LAP degradation products serve as a promising blood biomarker for liver fibrogenesis in mice, Fibrogenesis Tissue Repair, 8, 17, 10.1186/s13069-015-0034-9
Novo, 2008, Redox mechanisms in hepatic chronic wound healing and fibrogenesis, Fibrogenesis Tissue Repair, 1, 5, 10.1186/1755-1536-1-5
Richter, 2016, Reactive oxygen species and fibrosis: Further evidence of a significant liaison, Cell Tissue Res., 365, 591, 10.1007/s00441-016-2445-3
Liu, 2015, Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis, Redox Biol., 6, 565, 10.1016/j.redox.2015.09.009
Wu, 2018, Rapamycin Upregulates connective tissue growth factor expression in hepatic progenitor cells through TGF-β-Smad2 dependent signaling, Front. Pharm., 9, 877, 10.3389/fphar.2018.00877
Liang, 2016, The role of NADPH oxidases (NOXs) in liver fibrosis and the activation of myofibroblasts, Front. Physiol., 7, 17, 10.3389/fphys.2016.00017
Paik, 2011, The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in mice, Hepatology, 53, 1730, 10.1002/hep.24281
Matsumoto, 2018, The NOX1 isoform of NADPH oxidase is involved in dysfunction of liver sinusoids in nonalcoholic fatty liver disease, Free Radic. Biol. Med., 115, 412, 10.1016/j.freeradbiomed.2017.12.019
Sancho, P., Mainez, J., Crosas-Molist, E., Roncero, C., Fernández-Rodriguez, C.M., Pinedo, F., Huber, H., Eferl, R., Mikulits, W., and Fabregat, I. (2012). NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development. PLoS ONE, 7.
Andueza, 2018, NADPH oxidase 5 promotes proliferation and fibrosis in human hepatic stellate cells, Free Radic. Biol. Med., 126, 15, 10.1016/j.freeradbiomed.2018.07.013
Latella, 2018, Redox Imbalance in intestinal fibrosis: Beware of the TGFβ-1, ROS, and Nrf2 connection, Dig. Dis. Sci., 63, 312, 10.1007/s10620-017-4887-1
Xu, 2008, The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis, Lab. Investig. J. Tech. Methods Pathol., 88, 1068, 10.1038/labinvest.2008.75
Oh, 2012, Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling, Free Radic. Biol. Med., 52, 671, 10.1016/j.freeradbiomed.2011.11.012
Prestigiacomo, V., and Suter-Dick, L. (2018). Nrf2 protects stellate cells from Smad-dependent cell activation. PLoS ONE, 13.
Guan, 2018, NF-E2-related factor 2 suppresses intestinal fibrosis by inhibiting reactive oxygen species-dependent TGF-β1/SMADs pathway, Dig. Dis. Sci., 63, 366, 10.1007/s10620-017-4710-z
Chen, 2017, Schisandrin B attenuates CCl4-induced liver fibrosis in rats by regulation of Nrf2-ARE and TGF-β/Smad signaling pathways, Drug Des. Dev., 11, 2179
Piersma, 2017, Ascorbic acid promotes a TGFβ1-induced myofibroblast phenotype switch, Physiol. Rep., 5, e13324, 10.14814/phy2.13324
Jung, 2018, Dysregulation of NRF2 in cancer: From Molecular mechanisms to therapeutic opportunities, Biomology, 26, 57
Camarena, 2016, The epigenetic role of vitamin C in health and disease, Cell. Mol. Life Sci., 73, 1645, 10.1007/s00018-016-2145-x
Argemi, 2019, Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis, Nat. Commun., 10, 3126, 10.1038/s41467-019-11004-3
Yu, 2017, Epigenetically-regulated MicroRNA-9-5p suppresses the activation of hepatic stellate cells via TGFBR1 and TGFBR2, Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharm., 43, 2242, 10.1159/000484303
Davoodian, 2017, Effect of TGF-β/smad signaling pathway blocking on expression profiles of miR-335, miR-150, miR-194, miR-27a, and miR-199a of hepatic stellate cells (HSCs), Gastroenterol. Hepatol. Bed Bench, 10, 112
Bowen, 2013, MicroRNAs, transforming growth factor beta-1, and tissue fibrosis, J. Pathol., 229, 274, 10.1002/path.4119
Coll, 2015, Integrative miRNA and Gene expression profiling analysis of human quiescent hepatic stellate cells, Sci. Rep., 5, 11549, 10.1038/srep11549
Roderburg, 2013, miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis, J. Hepatol., 58, 736, 10.1016/j.jhep.2012.11.022
Roy, 2015, miR-30c and miR-193 are a part of the TGF-β-dependent regulatory network controlling extracellular matrix genes in liver fibrosis, J. Dig. Dis., 16, 513, 10.1111/1751-2980.12266
Benbow, 2018, Adeno-associated virus serotype 2 vector-mediated reintroduction of microrna-19b attenuates hepatic fibrosis, Hum. Gene Ther., 29, 674, 10.1089/hum.2017.035
Feili, 2018, MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells, Cell Biol. Int., 42, 1370, 10.1002/cbin.11022
Zou, 2019, MiR-146a attenuates liver fibrosis by inhibiting transforming growth factor-β1 mediated epithelial-mesenchymal transition in hepatocytes, Cell. Signal., 58, 1, 10.1016/j.cellsig.2019.01.012
Zou, 2017, MicroRNA-146a-5p attenuates liver fibrosis by suppressing profibrogenic effects of TGFβ1 and lipopolysaccharide, Cell. Signal., 39, 1, 10.1016/j.cellsig.2017.07.016
Wang, 2019, MicroRNA-134 deactivates hepatic stellate cells by targeting tgf-β activated kinase 1-binding protein 1, Biochem. Cell Biol., 97, 505, 10.1139/bcb-2018-0211
Tao, 2018, MicroRNA-942 mediates hepatic stellate cell activation by regulating BAMBI expression in human liver fibrosis, Arch. Toxicol., 92, 2935, 10.1007/s00204-018-2278-9
You, 2018, MicroRNA-125b promotes hepatic stellate cell activation and liver fibrosis by activating rhoa signaling, Mol. Nucleic Acids, 12, 57, 10.1016/j.omtn.2018.04.016
Yu, 2015, MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7, Lab. Investig. J. Tech. Methods Pathol., 95, 781, 10.1038/labinvest.2015.58
Zhu, 2018, MicroRNA-212 activates hepatic stellate cells and promotes liver fibrosis via targeting SMAD7, Biochem. Biophys. Res. Commun., 496, 176, 10.1016/j.bbrc.2018.01.019
Tu, 2015, MicroRNA-30 Protects against carbon tetrachloride-induced liver fibrosis by attenuating transforming growth factor beta signaling in hepatic stellate cells, Toxicol. Sci., 146, 157, 10.1093/toxsci/kfv081
Gupta, P., Sata, T.N., Yadav, A.K., Mishra, A., Vats, N., Hossain, M.M., Sanal, M.G., and Venugopal, S.K. (2019). TGF-β induces liver fibrosis via miRNA-181a-mediated down regulation of augmenter of liver regeneration in hepatic stellate cells. PLoS ONE, 14.
Yang, 2017, MiR-142-3p blocks TGF-β-induced activation of hepatic stellate cells through targeting TGFβRI, Life Sci., 187, 22, 10.1016/j.lfs.2017.08.017
Wei, 2019, miR-455-3p Alleviates Hepatic Stellate Cell Activation and Liver Fibrosis by Suppressing HSF1 Expression, Mol. Nucleic Acids, 16, 758, 10.1016/j.omtn.2019.05.001
Fan, 2015, MKL1 is an epigenetic modulator of TGF-β induced fibrogenesis, Biochim. Biophys. Acta, 1849, 1219, 10.1016/j.bbagrm.2015.07.013
Hu, 2015, The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis, Clin. Sci., 129, 305, 10.1042/CS20140012
Genz, 2019, Overexpression of miRNA-25-3p inhibits Notch1 signaling and TGF-β-induced collagen expression in hepatic stellate cells, Sci. Rep., 9, 8541, 10.1038/s41598-019-44865-1
Tang, P.M.-K., Zhang, Y.-Y., and Lan, H.-Y. (2018). LncRNAs in TGF-β-driven tissue fibrosis. Non-Coding RNA, 4.
Tu, 2017, TGF-β-induced hepatocyte lincRNA-p21 contributes to liver fibrosis in mice, Sci. Rep., 7, 2957, 10.1038/s41598-017-03175-0
Zhang, 2016, Bcl2 is a critical regulator of bile acid homeostasis by dictating Shp and lncRNA H19 function, Sci. Rep., 6, 20559, 10.1038/srep20559
Chen, 2015, Differential reactivation of fetal/neonatal genes in mouse liver tumors induced in cirrhotic and non-cirrhotic conditions, Cancer Sci., 106, 972, 10.1111/cas.12700
Zhu, 2019, H19/miR-148a/USP4 axis facilitates liver fibrosis by enhancing TGF-β signaling in both hepatic stellate cells and hepatocytes, J. Cell. Physiol., 234, 9698, 10.1002/jcp.27656
Song, 2018, Circular RNA in Liver: Health and diseases, Adv. Exp. Med. Biol., 1087, 245, 10.1007/978-981-13-1426-1_20
Chen, 2017, Microarray profiling of circular RNAs and the potential regulatory role of hsa_circ_0071410 in the activated human hepatic stellate cell induced by irradiation, Gene, 629, 35, 10.1016/j.gene.2017.07.078
Zhou, 2018, Preliminary screening and functional analysis of circular RNAs associated with hepatic stellate cell activation, Gene, 677, 317, 10.1016/j.gene.2018.08.052
Keene, 2007, RNA regulons: Coordination of post-transcriptional events, Nat. Rev. Genet., 8, 533, 10.1038/nrg2111
Wang, 2018, RNA binding proteins control transdifferentiation of hepatic stellate cells into myofibroblasts, Cell. Physiol. Biochem., 48, 1215, 10.1159/000491987
Chen, 2015, Epigenetic modifications by histone deacetylases: Biological implications and therapeutic potential in liver fibrosis, Biochimie, 116, 61, 10.1016/j.biochi.2015.06.016
Hardy, 2016, Epigenetics in liver disease: From biology to therapeutics, Gut, 65, 1895, 10.1136/gutjnl-2015-311292
Zhou, 2016, Angiogenic factor with G patch and FHA domains 1 (Aggf1) regulates liver fibrosis by modulating TGF-β signaling, Biochim. Biophys. Acta, 1862, 1203, 10.1016/j.bbadis.2016.02.002
Zeybel, 2017, A proof-of-concept for epigenetic therapy of tissue fibrosis: Inhibition of liver fibrosis progression by 3-deazaneplanocin A, Mol. J. Am. Soc. Gene, 25, 218
Arab, 2019, Enhancer of zeste homologue 2 inhibition attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis, Cell. Mol. Gastroenterol. Hepatol., 7, 197, 10.1016/j.jcmgh.2018.09.005
Lin, 2019, THU-375-Transcription factor TRIM33 controls liver progenitor cell towards hepatocyte differentiation through synergizing with SMAD2/3 following massive parenchymal loss, J. Hepatol., 70, e318, 10.1016/S0618-8278(19)30623-1
Wang, 2018, Histone deacetylase inhibitor suberoylanilide hydroxamic acid alleviates liver fibrosis by suppressing the transforming growth factor-β1 signal pathway, Hepatobiliary Pancreat. Dis. Int., 17, 423, 10.1016/j.hbpd.2018.09.013
Tu, 2007, Acetylation of Smad2 by the co-activator p300 regulates activin and transforming growth factor beta response, J. Biol. Chem., 282, 21187, 10.1074/jbc.M700085200
Inoue, 2007, Smad3 is acetylated by p300/CBP to regulate its transactivation activity, Oncogene, 26, 500, 10.1038/sj.onc.1209826
Janknecht, 1998, TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300, Genes Dev., 12, 2114, 10.1101/gad.12.14.2114
Wang, 2019, p300 acetyltransferase is a cytoplasm-to-nucleus shuttle for SMAD2/3 and TAZ nuclear transport in transforming growth factor β-stimulated hepatic stellate cells, Hepatology, 70, 1409, 10.1002/hep.30668
Jiang, 2019, Nicotinamide riboside protects against liver fibrosis induced by CCl4 via regulating the acetylation of Smads signaling pathway, Life Sci., 225, 20, 10.1016/j.lfs.2019.03.064
Regadera, 2016, Thyroid hormones inhibit TGF-β signaling and attenuate fibrotic responses, Proc. Natl. Acad. Sci. USA, 113, E3451
Munker, 2017, Can a fibrotic liver afford epithelial-mesenchymal transition?, World J. Gastroenterol., 23, 4661, 10.3748/wjg.v23.i26.4661
Taura, K., Iwaisako, K., Hatano, E., and Uemoto, S. (2016). Controversies over the epithelial-to-mesenchymal transition in liver fibrosis. J. Clin. Med., 5.
Choi, 2009, Epithelial-to-mesenchymal transitions in the liver, Hepatology, 50, 2007, 10.1002/hep.23196
Kisseleva, 2017, The origin of fibrogenic myofibroblasts in fibrotic liver, Hepatology, 65, 1039, 10.1002/hep.28948
Zeisberg, 2013, Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis, Am. J. Physiol. Cell Physiol., 304, C216, 10.1152/ajpcell.00328.2012
Wu, 2018, Autocrine transforming growth factor-β/activin A-Smad signaling induces hepatic progenitor cells undergoing partial epithelial-mesenchymal transition states, Biochimie, 148, 87, 10.1016/j.biochi.2018.03.003
Katsuno, 2019, Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition, Sci. Signal., 12, eaau8544, 10.1126/scisignal.aau8544
Sun, 2017, Advanced oxidation protein products induce hepatocyte epithelial-mesenchymal transition via a ROS-dependent, TGF-β/Smad signaling pathway, Cell Biol. Int., 41, 842, 10.1002/cbin.10792
Asahina, 2011, Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver, Hepatology, 53, 983, 10.1002/hep.24119
Li, 2016, Role of TGF-β signaling in differentiation of mesothelial cells to vitamin A-poor hepatic stellate cells in liver fibrosis, Am. J. Physiol. Gastrointest. Liver Physiol., 310, G262, 10.1152/ajpgi.00257.2015
Adams, 2018, Could endothelial TGFβ signaling be a promising new target for liver disease?, Expert Rev. Gastroenterol. Hepatol., 12, 637, 10.1080/17474124.2018.1477587
Ribera, 2017, A small population of liver endothelial cells undergoes endothelial-to-mesenchymal transition in response to chronic liver injury, Am. J. Physiol. Gastrointest. Liver Physiol., 313, G492, 10.1152/ajpgi.00428.2016
Dufton, 2017, Dynamic regulation of canonical TGFβ signalling by endothelial transcription factor ERG protects from liver fibrogenesis, Nat. Commun., 8, 895, 10.1038/s41467-017-01169-0
Vallée, A., Lecarpentier, Y., and Vallée, J.-N. (2017). Thermodynamic Aspects and Reprogramming Cellular Energy Metabolism during the Fibrosis Process. Int. J. Mol. Sci., 18.
Cantley, 2009, Understanding the Warburg effect: The metabolic requirements of cell proliferation, Science, 324, 1029, 10.1126/science.1160809
Pfeiffer, 2001, Cooperation and competition in the evolution of ATP-producing pathways, Science, 292, 504, 10.1126/science.1058079
Kottmann, 2012, Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-β, Am. J. Respir. Crit. Care Med., 186, 740, 10.1164/rccm.201201-0084OC
Li, J., Ghazwani, M., Liu, K., Huang, Y., Chang, N., Fan, J., He, F., Li, L., Bu, S., and Xie, W. (2017). Regulation of hepatic stellate cell proliferation and activation by glutamine metabolism. PLoS ONE, 12.
Bernard, 2018, Glutaminolysis is required for transforming growth factor-β1-induced myofibroblast differentiation and activation, J. Biol. Chem., 293, 1218, 10.1074/jbc.RA117.000444
Altman, 2016, From Krebs to clinic: Glutamine metabolism to cancer therapy, Nat. Rev. Cancer, 16, 619, 10.1038/nrc.2016.71
Takahashi, 2019, TGF-β2 is an exercise-induced adipokine that regulates glucose and fatty acid metabolism, Nat. Metab., 1, 291, 10.1038/s42255-018-0030-7
Starling, 2019, A new metabolic role for TGFβ2, Nat. Rev. Endocrinol., 15, 191, 10.1038/s41574-019-0183-9
Qin, 2018, Deletion of Smad4 reduces hepatic inflammation and fibrogenesis during nonalcoholic steatohepatitis progression, J. Dig. Dis., 19, 301, 10.1111/1751-2980.12599
Ko, 2006, Molecular components of the mammalian circadian clock, Hum. Mol. Genet., 15, R271, 10.1093/hmg/ddl207
Gekakis, 1998, Role of the CLOCK protein in the mammalian circadian mechanism, Science, 280, 1564, 10.1126/science.280.5369.1564
Chen, 2013, Deletion of clock gene Per2 exacerbates cholestatic liver injury and fibrosis in mice, Exp. Toxicol. Pathol., 65, 427, 10.1016/j.etp.2011.12.007
Chen, 2010, Loss of clock gene mPer2 promotes liver fibrosis induced by carbon tetrachloride, Hepatol. Res., 40, 1117, 10.1111/j.1872-034X.2010.00695.x
Janich, 2011, The circadian molecular clock creates epidermal stem cell heterogeneity, Nature, 480, 209, 10.1038/nature10649
Gast, 2012, Transforming growth factor-beta inhibits the expression of clock genes, Ann. N. Y. Acad. Sci., 1261, 79, 10.1111/j.1749-6632.2012.06640.x
Dong, 2016, Regulation of transforming growth factor-beta1 (TGF-β1)-induced pro-fibrotic activities by circadian clock gene BMAL1, Respir. Res., 17, 4, 10.1186/s12931-016-0320-0
Gibbs, 2014, An epithelial circadian clock controls pulmonary inflammation and glucocorticoid action, Nat. Med., 20, 919, 10.1038/nm.3599
Hwang, 2014, Circadian clock function is disrupted by environmental tobacco/cigarette smoke, leading to lung inflammation and injury via a SIRT1-BMAL1 pathway, FASEB J., 28, 176, 10.1096/fj.13-232629
Dikic, 2018, Mechanism and medical implications of mammalian autophagy, Nat. Rev. Mol. Cell Biol., 19, 349, 10.1038/s41580-018-0003-4
Li, 2014, Novel role of nuclear receptor Rev-erbα in hepatic stellate cell activation: Potential therapeutic target for liver injury, Hepatology, 59, 2383, 10.1002/hep.27049
Kojetin, 2014, REV-ERB and ROR nuclear receptors as drug targets, Nat. Rev. Drug Discov., 13, 197, 10.1038/nrd4100
Thomes, 2016, Rev-erb agonist and TGF-β similarly affect autophagy but differentially regulate hepatic stellate cell fibrogenic phenotype, Int. J. Biochem. Cell Biol., 81, 137, 10.1016/j.biocel.2016.11.007
Schrader, 2009, Senescence of activated stellate cells: Not just early retirement, Hepatology, 49, 1045, 10.1002/hep.22832
Serrano, 2014, Cellular senescence: From physiology to pathology, Nat. Rev. Mol. Cell Biol., 15, 482, 10.1038/nrm3823
Krizhanovsky, 2008, Senescence of activated stellate cells limits liver fibrosis, Cell, 134, 657, 10.1016/j.cell.2008.06.049
Wiemann, 2002, Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis, FASEB J., 16, 935, 10.1096/fj.01-0977com
Schafer, 2017, Cellular senescence mediates fibrotic pulmonary disease, Nat. Commun., 8, 14532, 10.1038/ncomms14532
Razdan, 2018, Telomere dysfunction promotes transdifferentiation of human fibroblasts into myofibroblasts, Aging Cell, 17, e12838, 10.1111/acel.12838
Bird, 2018, TGFβ inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence, Sci. Transl. Med., 10, eaan1230, 10.1126/scitranslmed.aan1230
Lu, 2018, Paracrine cellular senescence exacerbates biliary injury and impairs regeneration, Nat. Commun., 9, 1020, 10.1038/s41467-018-03299-5
Marcellin, 2013, Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: A 5-year open-label follow-up study, Lancet, 381, 468, 10.1016/S0140-6736(12)61425-1
Schuppan, 2018, Liver fibrosis: Direct antifibrotic agents and targeted therapies, Matrix Biol., 68–69, 435, 10.1016/j.matbio.2018.04.006
Dooley, 2012, TGF-β in progression of liver disease, Cell Tissue Res., 347, 245, 10.1007/s00441-011-1246-y
Wang, 2018, Expression, purification, and evaluation of in vivo anti-fibrotic activity for soluble truncated TGF-β receptor II as a cleavable His-SUMO fusion protein, World J. Microbiol. Biotechnol., 34, 181, 10.1007/s11274-018-2565-x
Dituri, 2019, TGF-β as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives, Semin. Liver Dis., 39, 53, 10.1055/s-0038-1676121
Melisi, 2008, LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis, Mol. Cancer Ther., 7, 829, 10.1158/1535-7163.MCT-07-0337
Luangmonkong, 2017, Evaluating the antifibrotic potency of galunisertib in a human ex vivo model of liver fibrosis, Br. J. Pharm., 174, 3107, 10.1111/bph.13945
Hammad, 2018, Galunisertib modifies the liver fibrotic composition in the Abcb4Ko mouse model, Arch. Toxicol., 92, 2297, 10.1007/s00204-018-2231-y
Ikenaga, 2017, Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal, Gut, 66, 1697, 10.1136/gutjnl-2016-312473
Ahn, 2016, Aminoacyl-tRNA synthetase interacting multi-functional protein 1 attenuates liver fibrosis by inhibiting TGFβ signaling, Int. J. Oncol., 48, 747, 10.3892/ijo.2015.3303
Zhang, 2017, Magnolol attenuates concanavalin a-induced hepatic fibrosis, inhibits cd4+ t helper 17 (Th17) cell differentiation and suppresses hepatic stellate cell activation: Blockade of smad3/smad4 signalling, Basic Clin. Pharm. Toxicol., 120, 560, 10.1111/bcpt.12749
Ji, 2018, Specific Inhibitor of smad3 (SIS3) attenuates fibrosis, apoptosis, and inflammation in unilateral ureteral obstruction kidneys by inhibition of transforming growth factor β (TGF-β)/Smad3 signaling, Med. Sci. Monit. Int., 24, 1633, 10.12659/MSM.909236
Ganai, 2017, Genistein attenuates D-GalN induced liver fibrosis/chronic liver damage in rats by blocking the TGF-β/Smad signaling pathways, Chem. Biol. Interact., 261, 80, 10.1016/j.cbi.2016.11.022
Liu, J., Kong, D., Qiu, J., Xie, Y., Lu, Z., Zhou, C., Liu, X., Zhang, R., and Wang, Y. (2019). Praziquantel Ameliorates ccl4 -induced liver fibrosis in mice by inhibiting TGF-β/smad signalling via upregulating smad7 in hepatic stellate cells. Br. J. Pharm.
Delire, 2015, Animal models for fibrotic liver diseases: What we have, what we need, and what is under development, J. Clin. Transl. Hepatol., 3, 53, 10.14218/JCTH.2014.00035
Hayashi, 2011, Animal models for the study of liver fibrosis: New insights from knockout mouse models, Am. J. Physiol. Gastrointest. Liver Physiol., 300, G729, 10.1152/ajpgi.00013.2011
Nakao, K., Minato, N., and Uemoto, S. (2015). TGF-β LAP Degradation Products, a Novel Biomarker and Promising Therapeutic Target for Liver Fibrogenesis. Innovative Medicine: Basic Research and Development, Springer.
Qiao, 2018, Redirecting TGF-β signaling through the β-catenin/foxo complex prevents kidney fibrosis, J. Am. Soc. Nephrol., 29, 557, 10.1681/ASN.2016121362
Akcora, 2018, Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12, Biochim. Biophys. Acta Mol. Basis Dis., 1864, 804, 10.1016/j.bbadis.2017.12.001
Kimura, 2017, Safety, tolerability, and preliminary efficacy of the anti-fibrotic small molecule pri-724, a cbp/β-catenin inhibitor, in patients with hepatitis c virus-related cirrhosis: A single-center, open-label, dose escalation phase 1 trial, EBioMedicine, 23, 79, 10.1016/j.ebiom.2017.08.016
Rahmo, 2018, Anti-fibrotic impact of Carvedilol in a CCl-4 model of liver fibrosis via serum microRNA-200a/SMAD7 enhancement to bridle TGF-β1/EMT track, Sci. Rep., 8, 14327, 10.1038/s41598-018-32309-1
Nguyen, 2018, Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition, Biochem. Biophys. Res. Commun., 495, 2649, 10.1016/j.bbrc.2017.12.143
Fan, 2017, Metformin mitigates carbon tetrachloride-induced TGF-β1/Smad3 signaling and liver fibrosis in mice, Biomed. Pharm., 90, 421, 10.1016/j.biopha.2017.03.079